Summary
SIRS-Lab produces molecular diagnostic systems to identify life-threatening infections. The main objective is to enable early and targeted antibiotic therapy of sepsis, the leading cause of death in hospitals. With expert knowledge in critical care medicine, microbiology, assay design, and gene expression, SIRS-Lab builds a unique diagnostic portfolio. Current products are the pathogen detection system VYOO and the LOOXSTER sample preparation kit.

	Clinical	Personal Care	Food	Pharma.	Water
Candida		-	-	-	-
E. coli		-
Enterobacteriaceae		-			-
Enterococcus		-
Legionella	-	-		-	-
Listeria	-	-		-	-
Neisseria		-	-	-	-
Staph aureus		-			-
Staph (MRSA)		-	-	-	-
Streptococcus		-	-	-	-

	Indicates manufacturer - click to request more information by email.
	Indicates that SIRS-Lab GmbH supplies products in this area either as a distributor or subsidiary.